Author

Casey Fazer

Observed names: C. Fazer, Casey A. Fazer, PA-C

Institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota)

Observed institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota)

OpenAlex ID: A5032842942

Management of Immune-Related Dermatitis and Mucositis Associated With Pembrolizumab in Metastatic Human Papillomavirus–Associated Squamous Cell Carcinoma of the Oropharynx

2020 · Casey Fazer, Katharine A. Price · JCO Oncology Practice · 10

Capecitabine for Salvage Treatment of Patients With Heavily Pretreated Human Papillomavirus–Associated Oropharynx Cancer With Distant Metastases

2023 · Anna C. Cooper, PA-C, Casey A. Fazer, PA-C, et al. · Journal of the Advanced Practitioner in Oncology · 1

A phase II study of pemetrexed and pembrolizumab in recurrent and/or metastatic salivary gland malignancies.

2022 · Katharine Andress Rowe Price, Nathan R. Foster, et al. · Journal of Clinical Oncology · 1

Capecitabine for Salvage Treatment of Patients with Heavily Pre-treated Human Papillomavirus-Associated Oropharynx Cancer (HPV-OPC) with Distant Metastases

2020 · C. Fazer, A.V. Chintakuntlawar, et al. · International Journal of Radiation Oncology*Biology*Physics · 1

Epidemiology, clinical characteristics and outcomes of intracranial metastases (ICM) in human papillomavirus positive (HPV+) oropharyngeal squamous cell carcinoma (OPSCC).

2025 · Binav Baral, Ramesh Lamichhane, et al. · Journal of Clinical Oncology

652 Early outcomes of an app acute checkpoint inhibitor (CPI) care clinic

2020 · Lisa Kottschade, Casey Fazer, et al. · Regular and Young Investigator Award Abstracts

Works count: 6

Citation count: 13

H-index: 1

I10-index: 1